Characterization of KRAS Mutational Regression in Oligometastatic Patients

BACKGROUND: We previously reported rare regressive genetic trajectories of KRAS pathogenic mutations as a specific hallmark of the genuine oligometastatic status in colorectal cancer (CRC). METHODS: Survival and prognostic impact of disease extent in 140 metastatic CRC patients were evaluated throug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaiano, Alessandro, de Vera d’Aragona, Roberta Penta, Trotta, Anna Maria, Santorsola, Mariachiara, Napolitano, Maria, Scognamiglio, Giosuè, Tatangelo, Fabiana, Grieco, Paolo, Zappavigna, Silvia, Granata, Vincenza, Perri, Francesco, Luce, Amalia, Savarese, Giovanni, Ianniello, Monica, Casillo, Marika, Petrillo, Nadia, Belli, Andrea, Izzo, Francesco, Nasti, Guglielmo, Caraglia, Michele, Scala, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354788/
https://www.ncbi.nlm.nih.gov/pubmed/35936004
http://dx.doi.org/10.3389/fimmu.2022.898561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354788/
https://www.ncbi.nlm.nih.gov/pubmed/35936004
http://dx.doi.org/10.3389/fimmu.2022.898561

Ejemplares similares